| P2093 | author name string | Najah Hadi | |
| | Hayder Chasib Assad | |
| | Reem Ali Shaker | |
| | Samer Hassan Abboud | |
| P2860 | cites work | The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy | Q26743433 |
| | The anthracyclines: will we ever find a better doxorubicin? | Q28184842 |
| | Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity | Q29614981 |
| | Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage | Q30439608 |
| | Therapeutic use of heparin beyond anticoagulation | Q33387579 |
| | Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange. | Q33685447 |
| | Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity | Q34203187 |
| | Extracellular superoxide dismutase and cardiovascular disease | Q34747179 |
| | Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro | Q34749618 |
| | Doxorubicin pathways: pharmacodynamics and adverse effects | Q35048393 |
| | Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome | Q35124414 |
| | Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics | Q35147247 |
| | Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity | Q35260701 |
| | In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity | Q35809052 |
| | Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity. | Q36467387 |
| | Heparin protection against Fe2+ -and Cu2+ -mediated oxidation of liposomes. | Q36833327 |
| | The anti-inflammatory effects of heparin and related compounds | Q36922642 |
| | Dual effect of heparin on Fe²⁺-induced cardiolipin peroxidation: implications for peroxidation of cytochrome c oxidase bound cardiolipin | Q37198499 |
| | Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a | Q37204101 |
| | Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; A clinical trial | Q37271573 |
| | Doxorubicin: the good, the bad and the ugly effect | Q37528487 |
| | Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies | Q37998724 |
| | The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study | Q38914599 |
| | Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. | Q40094247 |
| | Enoxaparin reduces H2O2-induced activation of human endothelial cells by a mechanism involving cell adhesion molecules and nuclear transcription factors | Q40177846 |
| | Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats | Q40826943 |
| | Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia | Q41846360 |
| | Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism | Q42647384 |
| | Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. | Q43166156 |
| | Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells | Q43586768 |
| | Doxorubicin-induced persistent oxidative stress to cardiac myocytes. | Q43615200 |
| | Preventive effects of enoxaparin and hesperidin in cerulein-induced acute pancreatitis in rats. | Q43706638 |
| | Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury | Q44181502 |
| | Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. | Q44539267 |
| | Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity | Q44641679 |
| | Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats | Q44743568 |
| | Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration | Q44880187 |
| | Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-α-caspase-3 activity | Q46717925 |
| | Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity | Q46768547 |
| | Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS). | Q46840009 |
| | Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals | Q46979860 |
| | Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients | Q47310363 |
| | Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes | Q47347418 |
| | The effect of low molecular weight heparin on survival in patients with advanced malignancy | Q47392658 |
| | Cardiac troponin-I, brain natriuretic peptide and endothelin-1 levels in a rat model of doxorubicin-induced cardiac injury | Q48903245 |
| | Effects of enoxaparin in the rat hippocampus following traumatic brain injury | Q48931467 |
| | Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats. | Q52887129 |
| | Heparin modulates the expression of genes encoding pro and anti-apoptotic proteins in endothelial cells exposed to intestinal ischemia and reperfusion in rats. | Q53032372 |
| | Effect of valsartan on cardiac senescence and apoptosis in a rat model of cardiotoxicity. | Q53148765 |
| | Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury. | Q53593146 |
| | Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. | Q53618473 |
| | Acute ischemic stroke and heparin treatments | Q73447343 |
| | Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats | Q79433429 |
| | Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity | Q82034595 |
| | Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats | Q82487965 |
| | [Low molecular weight heparin inhibits cell apoptosis in the placenta of rats with preeclampsia-like symptoms] | Q84378582 |
| | Factor-Xa inhibitors protect against systemic oxidant damage induced by peripheral-ischemia reperfusion | Q86705822 |
| | Antioxidants and tumor necrosis factor alpha-inhibiting activity of sesame oil against doxorubicin-induced cardiotoxicity | Q87124553 |
| P433 | issue | 1 | |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 3 | |
| P577 | publication date | 2018-01-10 | |
| P1433 | published in | BMC pharmacology & toxicology | Q27724429 |
| P1476 | title | Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis | |
| P478 | volume | 19 | |